1. Home
  2. MMC vs SNY Comparison

MMC vs SNY Comparison

Compare MMC & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMC
  • SNY
  • Stock Information
  • Founded
  • MMC 1871
  • SNY 1994
  • Country
  • MMC United States
  • SNY France
  • Employees
  • MMC N/A
  • SNY N/A
  • Industry
  • MMC Specialty Insurers
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMC Finance
  • SNY Health Care
  • Exchange
  • MMC Nasdaq
  • SNY Nasdaq
  • Market Cap
  • MMC 111.7B
  • SNY 127.2B
  • IPO Year
  • MMC N/A
  • SNY N/A
  • Fundamental
  • Price
  • MMC $233.63
  • SNY $49.37
  • Analyst Decision
  • MMC Hold
  • SNY Buy
  • Analyst Count
  • MMC 13
  • SNY 2
  • Target Price
  • MMC $239.85
  • SNY $62.50
  • AVG Volume (30 Days)
  • MMC 1.8M
  • SNY 2.4M
  • Earning Date
  • MMC 07-17-2025
  • SNY 07-24-2025
  • Dividend Yield
  • MMC 1.40%
  • SNY 4.48%
  • EPS Growth
  • MMC 3.44
  • SNY 39.56
  • EPS
  • MMC 8.15
  • SNY 5.45
  • Revenue
  • MMC $25,046,000,000.00
  • SNY $48,817,552,946.00
  • Revenue This Year
  • MMC $11.29
  • SNY $3.39
  • Revenue Next Year
  • MMC $5.67
  • SNY $7.05
  • P/E Ratio
  • MMC $28.68
  • SNY $17.77
  • Revenue Growth
  • MMC 7.56
  • SNY N/A
  • 52 Week Low
  • MMC $201.84
  • SNY $45.80
  • 52 Week High
  • MMC $248.00
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • MMC 59.14
  • SNY 38.24
  • Support Level
  • MMC $226.02
  • SNY $51.80
  • Resistance Level
  • MMC $231.90
  • SNY $52.41
  • Average True Range (ATR)
  • MMC 3.95
  • SNY 0.83
  • MACD
  • MMC 0.66
  • SNY -0.06
  • Stochastic Oscillator
  • MMC 94.62
  • SNY 16.44

About MMC Marsh & McLennan Companies Inc.

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Share on Social Networks: